TY - JOUR T1 - Hyperplastic polyposis syndrome and the risk of colorectal cancer JF - Gut JO - Gut SP - 470 LP - 471 DO - 10.1136/gutjnl-2011-300141 VL - 61 IS - 3 AU - Janina Orlowska Y1 - 2012/03/01 UR - http://gut.bmj.com/content/61/3/470.2.abstract N2 - I read with great interest the two reports by Boparai and coworkers in Gut on the increased risk of colorectal carcinoma (CRC) in 77 hyperplastic/serrated polyposis syndrome (HPS) patients during follow-up1 and in 347 HPS first-degree relatives (FDRs).2 To date, follow-ups have been performed in only 43/308 (14.0%) HPS patients and HPS coexistence with CRC in FDRs has been analysed in only 29/308 (9.4%) HPS patients described up to the end of 2009 (table 1).View this table:In this windowIn a new windowTable 1 CRC in HPS patients in the literature review from 1977 to the end of 2009* in comparison with the studies by Boparai et al in 20101 2Nevertheless, there are some points to be explained:The term ‘(sessile) serrated adenoma’ should be abbreviated as SSA, instead of SA (serrated adenoma). SSA, characterised by abnormal … ER -